verve therapeutics lilly - Search News

Order byBest matchMost fresh

News

Eli Lilly Buys Verve Therapeutics

· 13h · on MSN

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

Continue reading

· 12h · on MSN

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

· 16h · on MSN

Eli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.

12h

Eli Lilly Buys Verve Therapeutics: Aims To Permanently Lower Your Cholesterol

Eli Lilly (LLY) will acquire Verve Therapeutics (VERV) for up to $13.5/share, aiming to revolutionize cholesterol treatment.

pharmaphorum17h

Update: Rumour confirmed as Lilly buys Verve Therapeutics

Eli Lilly has confirmed plans for a $1.3 billion takeover bid for Verve Therapeutics, upgrading a collaboration between the ...

15hon MSN

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results